Definitive Healthcare (NASDAQ:DH) Reaches New 52-Week Low at $8.71

Definitive Healthcare Corp. (NASDAQ:DH) shares hit a new 52-week low during mid-day trading on Friday . The stock traded as low as $8.71 and last traded at $8.82, with a volume of 138695 shares changing hands. The stock had previously closed at $8.90.

Analyst Ratings Changes

DH has been the topic of several recent research reports. The Goldman Sachs Group cut their price objective on Definitive Healthcare from $17.00 to $10.50 and set a “neutral” rating on the stock in a report on Wednesday, August 16th. Morgan Stanley cut their price objective on Definitive Healthcare from $17.00 to $15.50 and set an “overweight” rating on the stock in a report on Tuesday, August 15th. Canaccord Genuity Group cut their price objective on Definitive Healthcare from $13.00 to $12.00 and set a “buy” rating on the stock in a report on Tuesday, August 15th. Robert W. Baird downgraded Definitive Healthcare from an “outperform” rating to a “neutral” rating and set a $13.00 price objective on the stock. in a report on Monday, July 24th. Finally, Bank of America cut their price objective on Definitive Healthcare from $12.00 to $10.50 and set a “neutral” rating on the stock in a report on Tuesday, August 15th. Four analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, Definitive Healthcare has an average rating of “Moderate Buy” and an average price target of $12.69.

Definitive Healthcare Price Performance

The company has a market capitalization of $1.01 billion, a price-to-earnings ratio of -59.47, a P/E/G ratio of 18.54 and a beta of 0.74. The company has a debt-to-equity ratio of 0.17, a quick ratio of 2.84 and a current ratio of 2.84. The business has a 50 day moving average price of $10.63 and a 200-day moving average price of $10.58.

Definitive Healthcare (NASDAQ:DH) last issued its earnings results on Monday, August 14th. The company reported $0.08 EPS for the quarter, beating analysts’ consensus estimates of $0.05 by $0.03. Definitive Healthcare had a positive return on equity of 0.29% and a negative net margin of 5.31%. The business had revenue of $60.96 million during the quarter, compared to analyst estimates of $61.00 million. During the same period in the previous year, the company posted ($0.01) EPS. The firm’s revenue was up 11.7% compared to the same quarter last year. Research analysts predict that Definitive Healthcare Corp. will post 0.02 EPS for the current fiscal year.

Insiders Place Their Bets

In other Definitive Healthcare news, Director Sea Vii Management, Llc sold 6,656 shares of the business’s stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $9.39, for a total transaction of $62,499.84. Following the completion of the sale, the director now directly owns 1,441,657 shares of the company’s stock, valued at approximately $13,537,159.23. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 15.27% of the company’s stock.

Hedge Funds Weigh In On Definitive Healthcare

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Metropolitan Life Insurance Co NY purchased a new position in Definitive Healthcare in the second quarter valued at approximately $28,000. Ameritas Investment Partners Inc. purchased a new position in Definitive Healthcare in the second quarter valued at approximately $41,000. Bessemer Group Inc. purchased a new position in Definitive Healthcare in the first quarter valued at approximately $49,000. Ensign Peak Advisors Inc purchased a new position in Definitive Healthcare in the third quarter valued at approximately $53,000. Finally, PNC Financial Services Group Inc. lifted its stake in Definitive Healthcare by 34.6% in the fourth quarter. PNC Financial Services Group Inc. now owns 5,092 shares of the company’s stock valued at $56,000 after purchasing an additional 1,309 shares during the last quarter.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.